Researcher profile
Riccardo Bortoletto
Affiliations
Organizations
Public evidence
2 connected articles
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis.2024 · Europe PMCCannabis Use in Autism: Reasons for Concern about Risk for Psychosis.2022 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.